Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathew

Showing results (831-840 of 845) with videos related to

Pageof 85
Sort By:
The American Journal of Psychiatry|March 3, 2021
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled TrialSara Costi, Laurel S Morris, Katherine A Kirkwood, et al.
International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.
Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Insula uses overlapping codes for emotion in self and othersJiayang Xiao, Joshua A Adkinson, Anusha B Allawala, et al.
Translational Psychiatry|February 2, 2021
Combined effects of genotype and childhood adversity shape variability of DNA methylation across ageDarina Czamara, Elleke Tissink, Johanna Tuhkanen, et al.
Brain Stimulation|December 22, 2023
Stereo-EEG-guided network modulation for psychiatric disorders: Surgical considerationsSameer A Sheth, Ben Shofty, Anusha Allawala, et al.
The New England Journal of Medicine|May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major DepressionAmit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.
Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
Brain Stimulation|October 20, 2024
Towards objective, temporally resolved neurobehavioral predictors of emotional stateKatherine E Kabotyanski, Han G Yi, Rahul Hingorani, et al.
Pageof 85

Showing results (831-840 of 845) with videos related to

Sort By:
Pageof 85
The American Journal of Psychiatry|March 3, 2021
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled TrialSara Costi, Laurel S Morris, Katherine A Kirkwood, et al.
International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.
Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Insula uses overlapping codes for emotion in self and othersJiayang Xiao, Joshua A Adkinson, Anusha B Allawala, et al.
Translational Psychiatry|February 2, 2021
Combined effects of genotype and childhood adversity shape variability of DNA methylation across ageDarina Czamara, Elleke Tissink, Johanna Tuhkanen, et al.
Brain Stimulation|December 22, 2023
Stereo-EEG-guided network modulation for psychiatric disorders: Surgical considerationsSameer A Sheth, Ben Shofty, Anusha Allawala, et al.
The New England Journal of Medicine|May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major DepressionAmit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.
Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
Brain Stimulation|October 20, 2024
Towards objective, temporally resolved neurobehavioral predictors of emotional stateKatherine E Kabotyanski, Han G Yi, Rahul Hingorani, et al.
Pageof 85